![]() Back to Annual Meeting
|
|
![]() Back to Annual Meeting
|
APHA Scientific Session and Event Listing |
Christopher F. Davis, BS1, Bruce F. Coles, PhD2, Robert A. Bednarczyk, MS1, Michelle Cummings, BS1, and Louise-Anne McNutt, PhD3. (1) Dept. of Epidemiology and Biostatistics, SUNY, University at Albany, School of Public Health, 1 University Place, Rensselaer, NY 12144, 518.402.0285, cd5341@albany.edu, (2) Bureau STD control, New York State Department of Health, Corning Tower, Empire State Plaza, Albany, NY 12237, (3) Associate Professor, Department of Epidemiology & Biostatistics, School of Public Health, University at Albany, State University of New York, 1 University Place, GEC 125, Rensselaer, NY 12144
Background: The Centers for Disease Control and Prevention encourages states to legalize patient-delivered partner therapy (PDPT) for Chlamydia and gonorrhea, that is, allow physicians/providers to give their patients medication or a prescription intended for their sexual partners without the partner having a medical encounter.
Objective: To assess current sexually transmitted disease (STD) control practices in New York State counties, and gather perspectives on PDPT and alternative treatment methods.
Methods: A cross-sectional study reviewed county health department websites to assess information provided to residents regarding STD treatment, including clinic location and hours. County officials were interviewed from January to March 2007 by telephone, to determine available treatments, current partner notification practices and PDPT perspectives. Descriptive statistics included frequencies and proportions.
Results: County officials were split about legalizing PDPT, with 45% for, 45% against, and 10% undecided. Reasons for support included treating more infected individuals (61%) and improving STD control (29%). Reasons for lack of support included contraindication/side effects (28%), fear of medication not reaching partners (28%) and malpractice concerns (20%). Analysis by STD caseload showed that 67% of counties with high case loads (400-5525 Chlamydia and gonorrhea cases annually) were against the legalization. About half of professionals interviewed supported expanding disease control efforts through distribution of educational materials (45%) and express care for partners in STD clinics (67%).
Discussion: County officials' perspectives are polarized, reflecting the difficulty of negotiating less than optimal options for STD control. The role of epidemiologists in STD policy formation will be discussed.
Learning Objectives:
Keywords: STD Prevention, Chlamydia
Presenting author's disclosure statement:
Any relevant financial relationships? No
Any institutionally-contracted trials related to this submission?
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
The 135th APHA Annual Meeting & Exposition (November 3-7, 2007) of APHA